Template:Unstable angina / NSTEMI: Difference between revisions
Jump to navigation
Jump to search
mNo edit summary |
No edit summary |
||
(69 intermediate revisions by 14 users not shown) | |||
Line 1: | Line 1: | ||
{| class="infobox bordered" style="width: 15em; text-align: left; font-size: 90%; background:AliceBlue" | {| class="infobox bordered" style="width: 15em; text-align: left; font-size: 90%; background:AliceBlue" | ||
|- bgcolor="LightGrey" | |||
! | |||
[[Acute coronary syndrome|Acute Coronary Syndrome Main Page]] | |||
|- | |||
! | |||
|- | |- | ||
| colspan="1" style="text-align:center; background:DarkGray" | | | colspan="1" style="text-align:center; background:DarkGray" | | ||
Line 16: | Line 22: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Unstable angina / | [[Unstable angina / non ST elevation myocardial infarction (patient information)|Patient Information]] | ||
|- | |- | ||
! | ! | ||
Line 28: | Line 34: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Unstable angina / non ST elevation myocardial infarction classification | Classification]] | |||
|- | |- | ||
! | ! | ||
Line 34: | Line 40: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
:[[Unstable angina pathophysiology | [[Unstable angina / non ST elevation myocardial infarction pathophysiology | Pathophysiology]] | ||
|- bgcolor="Pink" | |||
! | |||
:[[Unstable angina pathophysiology|Unstable Angina]] | |||
|- bgcolor="Pink" | |||
! | |||
:[[Non ST elevation myocardial infarction pathophysiology|Non-ST Elevation Myocardial Infarction]] | |||
|- | |- | ||
! | ! | ||
Line 40: | Line 54: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Chest pain differential diagnosis|Differentiating Unstable Angina/Non-ST Elevation Myocardial Infarction from other Disorders]] | |||
|- | |- | ||
! | ! | ||
Line 52: | Line 66: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Unstable angina risk stratification and prognosis|Risk Stratification]] | [[Unstable angina / non ST elevation myocardial infarction risk stratification and prognosis|Risk Stratification]] | ||
|- | |- | ||
! | ! | ||
Line 58: | Line 72: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Unstable angina / non ST elevation myocardial infarction natural history, complications and prognosis|Natural History, Complications and Prognosis]] | |||
|- | |- | ||
! | ! | ||
Line 64: | Line 78: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
:[[Unstable angina | Special Groups | ||
|- | |||
! | |- bgcolor="Pink" | ||
! | |||
:[[Unstable angina / non ST elevation myocardial infarction and women | Women]] | |||
|- bgcolor="Pink" | |||
! | |||
:[[Unstable angina / non ST elevation myocardial infarction and heart failure/cardiogenic shock| Heart Failure and Cardiogenic Shock]] | |||
|- bgcolor="Pink" | |||
! | |||
:[[Unstable angina / non ST elevation myocardial infarction and perioperative NSTE-ACS related to noncardiac surgery| Perioperative NSTE-ACS Related to Noncardiac Surgery]] | |||
|- bgcolor="Pink" | |||
! | |||
:[[Unstable angina / non ST elevation myocardial infarction and stress (Takotsubo) cardiomyopathy| Stress (Takotsubo) Cardiomyopathy]] | |||
|- bgcolor="Pink" | |||
! | |||
:[[Unstable angina / non ST elevation myocardial infarction and diabetes mellitus| Diabetes Mellitus]] | |||
|- bgcolor="Pink" | |||
! | |||
:[[Unstable angina / non ST elevation myocardial infarction and post CABG patients| Post CABG Patients]] | |||
|- bgcolor="Pink" | |||
! | |||
:[[Unstable angina / non ST elevation myocardial infarction and the elderly|Older Adults]] | |||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Unstable angina | :[[Unstable angina / non ST elevation myocardial infarction and chronic kidney disease | Chronic Kidney Disease]] | ||
|- | |||
|- bgcolor="Pink" | |||
! | ! | ||
:[[Unstable angina / non ST elevation myocardial infarction and ACS with angiographically normal coronary arteries |Angiographically Normal Coronary Arteries ]] | |||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[ | :[[Unstable angina / non ST elevation myocardial infarction and prinzmetal's angina |Variant (Prinzmetal's) Angina]] | ||
|- | |||
|- bgcolor="Pink" | |||
! | ! | ||
:[[Unstable angina / non ST elevation myocardial infarction and substance abuse|Substance Abuse]] | |||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Unstable angina / non ST elevation myocardial infarction | :[[Unstable angina / non ST elevation myocardial infarction and cardiovascular syndrome X | Cardiovascular "Syndrome X"]] | ||
|- | |- | ||
! | ! | ||
Line 94: | Line 138: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Unstable angina / non ST elevation myocardial infarction symptoms|History | [[Unstable angina / non ST elevation myocardial infarction history and symptoms|History and Symptoms]] | ||
|- | |- | ||
! | ! | ||
Line 106: | Line 150: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Unstable angina / | Laboratory Findings | ||
|- bgcolor="LightSkyBlue" | |||
! | |||
:[[Unstable angina / non ST elevation myocardial infarction blood studies|Blood Studies]] | |||
|- bgcolor="LightSkyBlue" | |||
! | |||
:[[Unstable angina / non ST elevation myocardial infarction biomarkers|Biomarkers]] | |||
|- | |- | ||
! | ! | ||
Line 112: | Line 164: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Unstable angina / | [[Unstable angina / non ST elevation myocardial infarction electrocardiogram|Electrocardiogram]] | ||
|- | |- | ||
! | ! | ||
Line 118: | Line 170: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Unstable angina / | [[Unstable angina / non ST elevation myocardial infarction chest x-ray|Chest X Ray]] | ||
|- | |- | ||
! | ! | ||
Line 124: | Line 176: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Unstable angina / | [[Unstable angina / non ST elevation myocardial infarction echocardiogram | Echocardiography]] | ||
|- | |- | ||
! | ! | ||
Line 130: | Line 182: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Unstable angina / | [[Unstable angina / non ST elevation myocardial infarction coronary angiography| Coronary Angiography]] | ||
|- | |- | ||
! | ! | ||
Line 136: | Line 188: | ||
|- bgcolor="CadetBlue" | |- bgcolor="CadetBlue" | ||
! | ! | ||
Treatment | '''Treatment''' | ||
|- | |- | ||
! | ! | ||
Line 142: | Line 194: | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[Unstable angina / non ST elevation myocardial infarction | [[Unstable angina / non ST elevation myocardial infarction primary prevention | Primary Prevention]] | ||
|- | |- | ||
! | ! | ||
Line 148: | Line 200: | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[Unstable angina / non ST elevation myocardial infarction immediate management | Immediate Management]] | |||
|- | |- | ||
! | |||
|- bgcolor="PaleTurquoise" | |||
! | ! | ||
[[Unstable angina / non ST elevation myocardial infarction anti-ischemic and analgesic therapy|Anti-Ischemic and Analgesic Therapy]] | |||
|- | |||
! | |||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[Unstable angina / non ST elevation myocardial infarction Cholesterol Management|Cholesterol Management]] | |||
|- | |- | ||
! | |||
|- bgcolor="PaleTurquoise" | |||
! | ! | ||
Antitplatelet Therapy | |||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
:[[ | :[[Unstable angina/NSTEMI Antiplatelet therapy recommendations|Antiplatelet therapy recommendations]] | ||
|- | |||
|- bgcolor="PaleTurquoise" | |||
! | ! | ||
:[[Unstable angina / non ST elevation myocardial infarction aspirin therapy|Aspirin]] | |||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[Unstable angina / non ST elevation myocardial infarction | :[[Unstable angina / non ST elevation myocardial infarction thienopyridines|Thienopyridines]] | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[Unstable angina / non ST elevation myocardial infarction | :[[Unstable angina / non ST elevation myocardial infarction GPIIb/IIIa inhibitor|Glycoprotein IIb/IIIa Inhibitor]] | ||
|- | |- | ||
! | ! | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[Unstable angina / non ST elevation myocardial infarction anticoagulant therapy | Anticoagulant Therapy]] | |||
|- | |- | ||
! | ! | ||
Line 184: | Line 244: | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[Unstable angina / non ST elevation myocardial infarction additional management considerations for antiplatelet and anticoagulant therapy | Additional Management Considerations for Antiplatelet and Anticoagulant Therapy]] | |||
|- | |- | ||
! | ! | ||
Line 190: | Line 250: | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[Unstable angina / non ST elevation myocardial infarction Risk Stratification Before Discharge for Patients With an Ischemia-Guided Strategy of NSTE-ACS |Risk Stratification Before Discharge for Patients With an Ischemia-Guided Strategy of NSTE-ACS]] | |||
|- | |- | ||
! | ! | ||
Line 196: | Line 256: | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
'''Mechanical Reperfusion''' | |||
|- | |- | ||
! | |||
|- bgcolor="PaleTurquoise" | |||
! | ! | ||
:[[Unstable angina / non ST elevation myocardial infarction initial conservative versus initial invasive strategies | Initial Conservative Versus Initial Invasive Strategies]] | |||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[Unstable angina / non ST elevation myocardial infarction | :[[Unstable angina / non ST elevation myocardial infarction recommendations for PCI | PCI]] | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
:[[Unstable angina / non ST elevation myocardial infarction recommendations for CABG | CABG]] | |||
|- | |- | ||
! | ! | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[Unstable angina and complications of bleeding and transfusion|Complications of Bleeding and Transfusion]] | |||
|- | |- | ||
! | ! | ||
Line 220: | Line 282: | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
:[[Unstable angina / non ST elevation myocardial infarction | Discharge Care | ||
|- | |||
|- bgcolor="PaleTurquoise" | |||
! | |||
:[[Unstable angina / non ST elevation myocardial infarction medical regimen and use of medications | Medical Regimen]] | |||
|- bgcolor="PaleTurquoise" | |||
! | ! | ||
:[[Unstable angina / non ST elevation myocardial infarction post-discharge follow-up | Post-Discharge Follow-Up]] | |||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
:[[Unstable angina / non ST elevation myocardial infarction | :[[Unstable angina / non ST elevation myocardial infarction cardiac rehabilitation | Cardiac Rehabilitation]] | ||
|- | |- | ||
! | ! | ||
Line 232: | Line 300: | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[Unstable angina and | [[Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention | Long-Term Medical Therapy and Secondary Prevention]] | ||
|- | |- | ||
! | ! | ||
Line 238: | Line 306: | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[ICD implantation within 40 days of myocardial infarction]] | |||
|- | |- | ||
! | |||
|- bgcolor="PaleTurquoise" | |||
! | ! | ||
[[ICD within 90 days of revascularization]] | |||
|- | |||
! | |||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[Unstable angina / non ST elevation myocardial infarction cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | |||
|- | |- | ||
! | ! | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[Unstable angina / non ST elevation myocardial infarction future or investigational therapies|Future or Investigational Therapies]] | |||
|- | |- | ||
! | ! | ||
|- bgcolor=" | |- bgcolor="CadetBlue" | ||
! | ! | ||
Case Studies | |||
|- | |- | ||
! | ! | ||
Line 262: | Line 336: | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[Unstable angina / non ST elevation myocardial infarction | [[Unstable angina / non ST elevation myocardial infarction case study one|Case #1]] | ||
|- | |- | ||
! | ! | ||
Line 346: | Line 420: | ||
|- bgcolor="LightYellow" | |- bgcolor="LightYellow" | ||
! | ! | ||
[http://blogsearch.google.com/blogsearch?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&ie=UTF-8&oe=utf-8&rls=org.mozilla:en-US:official&client=firefox-a&um=1&sa=N&tab=wb Blogs on {{PAGENAME}}] | [http://blogsearch.google.com/blogsearch?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&ie=UTF-8&oe=utf-8&rls=org.mozilla:en-US:official&client=firefox-a&um=1&sa=N&tab=wb Blogs on {{PAGENAME}}] | ||
|- | |- | ||
! | ! |
Latest revision as of 20:04, 27 February 2020
Unstable angina / NSTEMI Microchapters |
Differentiating Unstable Angina/Non-ST Elevation Myocardial Infarction from other Disorders |
Special Groups |
Diagnosis |
Laboratory Findings |
Treatment |
Antitplatelet Therapy |
Additional Management Considerations for Antiplatelet and Anticoagulant Therapy |
Risk Stratification Before Discharge for Patients With an Ischemia-Guided Strategy of NSTE-ACS |
Mechanical Reperfusion |
Discharge Care |
Case Studies |
Unstable angina / NSTEMI On the Web |
Risk calculators and risk factors for Unstable angina / NSTEMI |